Showing results (431-440 of 439) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 439 results.
BMC Health Services Research|August 12, 2025
Implementation strategies to integrate HIV and hypertension care in Kampala and Wakiso districts, Uganda: study protocol for a stepped wedge cluster randomized trial (PULESA-Uganda)Chris T Longenecker, John Baptist Kiggundu, Florence Ayebare, et al.
BMJ Open|July 21, 2022
Patient preferences for facility-based management of hypertension and diabetes in rural Uganda: a discrete choice experimentSarah Eg Moor, Andrew K Tusubira, Dallas Wood, et al.
The Canadian Journal of Cardiology|December 14, 2020
Anticoagulation for Patients With Atrial Fibrillation and End-Stage Renal Disease on Dialysis: A National SurveyLaura F Halperin, May K Lee, Janet Liew, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bileS K Balani, X Xu, V Pratha, et al.
Annals of Internal Medicine|July 6, 2000
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trialS K Swan, D W Rudy, K C Lasseter, et al.
Journal of Clinical Pharmacology|December 19, 2003
Pharmacokinetics of etoricoxib in patients with renal impairmentNancy G B Agrawal, Catherine Z Matthews, Ralph S Mazenko, et al.
Vaccine|March 2, 2010
In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10) colony-forming unitsC E Lyon, K S Sadigh, M P Carmolli, et al.
The New England Journal of Medicine|January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 YearsPatricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEPJennifer K Litton, Meredith M Regan, Lajos Pusztai, et al.
Pageof 44